CIRS Group has compiled and summarized the latest global cosmetics regulatory developments in April 2026, covering industry news, new regulations, policy adjustments, and regulatory trends, helping companies stay compliant and fully informed of the evolving global cosmetics regulatory landscape.
On April 15, 2026, the Minnesota Pollution Control Agency (MPCA) announced a second extension of the initial PFAS products reporting deadline, moving it from July 1, 2026 to September 15, 2026. Upon completion of the initial report, subsequent annual reports are due each February 1. Manufacturers unable to meet the deadline may apply for a single 90-day extension (to December 14, 2026).
Globally, the regulatory landscape for exosome cosmetics exhibits significant variability. This article systematically reviews the management measures, regulations, and ethical standards concerning exosome cosmetics in various countries/regions, including the United States, the European Union, Japan, South Korea, Taiwan, and mainland China. It explores the context of compliance and prohibitions, as well as their impact on industry development, providing comprehensive global regulatory compliance guidance for cosmetic companies.
On March 11, 2026, the U.S. Food and Drug Administration (FDA) launched a new unified platform for analyzing adverse event reports, known as the FDA Adverse Event Monitoring System (AEMS). This initiative marks a significant milestone in the agency’s mission to modernize and enhance transparency regarding the safety of regulated products.On March 11, 2026, the U.S. Food and Drug Administration (FDA) launched a new unified platform for analyzing adverse event reports, known as the FDA Adverse Event Monitoring System (AEMS). This initiative marks a significant milestone in the agency’s mission to modernize and enhance transparency regarding the safety of regulated products.
In February, the U.S. Food and Drug Administration (FDA) announced updates to the Cosmetics Direct electronic submission portal, along with the user guide and other materials, to assist in the biennial registration renewal of cosmetic product facilities as required under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA).
Per- and polyfluoroalkyl substances (PFAS) are increasingly becoming a focal point of global concern due to their potential long-term impacts on the environment and human health. As a class of synthetic chemicals characterized by high stability and widespread applications, PFAS are facing increasingly stringent regulatory scrutiny in the cosmetics sector. This article explores the physicochemical properties and potential health risks of PFAS, and systematically reviews the evolving global regulatory landscape related to their use in cosmetics. It aims to help cosmetic enterprises gain a comprehensive understanding of regulatory requirements, mitigate compliance risks, enhance product safety, and strengthen competitiveness in international markets.
This article compiles and summarizes the latest developments in cosmetics regulations in China and globally as of September 2025, covering industry news, newly issued regulations, relevant policy adjustments, and regulatory requirements. It aims to assist enterprises in ensuring compliance and keeping up with global cosmetics regulatory trends.
On September 12, 2025, the U.S. Food and Drug Administration (FDA) announced the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products, an interactive tool designed to facilitate the public’s ability to query real-time adverse event data on cosmetic products. The user-friendly platform allows users to download report listings or data sets, with reports being updated daily to include the most recent submissions.
This regulation restricts the manufacture, sale, and distribution of cosmetic products in the state of Washington that contain intentionally added formaldehyde or formaldehyde releasers. The objective is to reduce consumer exposure to formaldehyde through the use of cosmetic products, due to its known health risks. The regulation will enter into force on September 28, 2025.
This article reviews and summarizes the latest international cosmetic regulatory developments in the first half of 2025, with a focus on the European and American markets. It covers key updates from the EU, the UK, the US, Canada, and other relevant countries and regions. The aim is to help enterprises stay informed of regulatory changes, ensure compliant product launches, and enhance global market competitiveness.
